Passaro, C., Volpe, M., Botta, G., Scamardella, E., Perruolo, G., Gillespie, D., . . . Portella, G. (2014). PARP inhibitor olaparib increases the oncolytic activity of dl922‐947 in in vitro and in vivo model of anaplastic thyroid carcinoma. Mol Oncol.

Passaro, Carmela, Massimiliano Volpe, Ginevra Botta, Eloise Scamardella, Giuseppe Perruolo, David Gillespie, Silvana Libertini, and Giuseppe Portella. "PARP Inhibitor Olaparib Increases the Oncolytic Activity of Dl922‐947 in In vitro and In vivo Model of Anaplastic Thyroid Carcinoma." Mol Oncol 2014.

Passaro, Carmela, et al. "PARP Inhibitor Olaparib Increases the Oncolytic Activity of Dl922‐947 in In vitro and In vivo Model of Anaplastic Thyroid Carcinoma." Mol Oncol 2014.